Ah....Mozz - the reason why we are here is that the FDA don't think we have a decent safety/risk profile and we are spending an age trying to convince them otherwise.
A Type D meeting was called to address the partial clinical hold on the 2mg/kg dosing. No other dose below that, even one that is just 25% less, didn't meet endpoints.
Where we at?, page-681
-
- There are more pages in this discussion • 26 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
20.5¢ |
Change
-0.005(2.38%) |
Mkt cap ! $71.79M | |||
| Open | High | Low | Value | Volume |
| 21.0¢ | 21.0¢ | 20.5¢ | $16.32K | 77.77K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 89251 | 20.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 21.0¢ | 52634 | 5 |
View Market Depth
| Last trade - 10.38am 11/10/2024 (20 minute delay) ? |
| PAR (ASX) Chart |